Epoxyeicosatrienoic Acids Contribute With Altered Nitric Oxide and Endothelin-1 Pathways to Conduit Artery Endothelial Dysfunction in Essential Hypertension

Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension

(2011) Ji Gao et al.   JOURNAL OF HYPERTENSION

Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

(2011) Jeremy Bellien et al.   PHARMACOLOGY & THERAPEUTICS

Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling

(2010) Ulrich Förstermann et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endothelial dysfunction and vascular disease

(2009) P. M. Vanhoutte et al.   Acta Physiologica

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

(2009) Michael A Weber et al.   LANCET

Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease

(2008) Pietro Minuz et al.   HYPERTENSION

Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode

(2008) Sophie Goulitquer et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES